Anecio, Manelyn .
HRN: 12-84-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2024
CEFUROXIME 1.5GM (VIAL)
05/26/2024
05/29/2024
IV
1.5 G
Q8
For CS For Breech
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes